BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 31420527)

  • 1. Differential Roles of Accumbal GSK3
    Shi X; Barr JL; von Weltin E; Wolsh C; Unterwald EM
    J Pharmacol Exp Ther; 2019 Nov; 371(2):339-347. PubMed ID: 31420527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38 mitogen-activated protein kinase activation in amygdala mediates κ opioid receptor agonist U50,488H-induced conditioned place aversion.
    Zan GY; Wang Q; Wang YJ; Chen JC; Wu X; Yang CH; Chai JR; Li M; Liu Y; Hu XW; Shu XH; Liu JG
    Neuroscience; 2016 Apr; 320():122-8. PubMed ID: 26826330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
    Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
    J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen Synthase Kinase 3β in the Ventral Hippocampus is Important for Cocaine Reward and Object Location Memory.
    Barr JL; Shi X; Zaykaner M; Unterwald EM
    Neuroscience; 2020 Jan; 425():101-111. PubMed ID: 31783102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females.
    Robles CF; McMackin MZ; Campi KL; Doig IE; Takahashi EY; Pride MC; Trainor BC
    Behav Brain Res; 2014 Apr; 262():84-93. PubMed ID: 24445073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.
    McLaughlin JP; Land BB; Li S; Pintar JE; Chavkin C
    Neuropsychopharmacology; 2006 Apr; 31(4):787-94. PubMed ID: 16123754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference.
    Suzuki T; Shiozaki Y; Masukawa Y; Misawa M; Nagase H
    Jpn J Pharmacol; 1992 Apr; 58(4):435-42. PubMed ID: 1328733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice.
    Bagdas D; Muldoon PP; AlSharari S; Carroll FI; Negus SS; Damaj MI
    Neuropharmacology; 2016 Mar; 102():236-43. PubMed ID: 26639043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
    Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
    Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
    Funada M; Suzuki T; Narita M; Misawa M; Nagase H
    Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
    Kuzmin AV; Semenova S; Gerrits MA; Zvartau EE; Van Ree JM
    Eur J Pharmacol; 1997 Mar; 321(3):265-71. PubMed ID: 9085036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term effects of stress and kappa opioid receptor activation on conditioned place aversion in male and female California mice.
    Laman-Maharg AR; Copeland T; Sanchez EO; Campi KL; Trainor BC
    Behav Brain Res; 2017 Aug; 332():299-307. PubMed ID: 28625549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
    Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice.
    Huang P; Gentile TA; Muschamp JW; Liu-Chen LY
    BMC Res Notes; 2020 Aug; 13(1):384. PubMed ID: 32799930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats.
    Mori T; Nomura M; Nagase H; Narita M; Suzuki T
    Psychopharmacology (Berl); 2002 Apr; 161(1):17-22. PubMed ID: 11967626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors.
    Ramiro-Fuentes S; Ortiz O; Moratalla R; Fernandez-Espejo E
    Neuroscience; 2010 May; 167(2):205-15. PubMed ID: 20167255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms.
    Schindler AG; Li S; Chavkin C
    Neuropsychopharmacology; 2010 Aug; 35(9):1932-42. PubMed ID: 20445500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone and nalmefene attenuate cocaine place preference in male mice.
    Windisch KA; Reed B; Kreek MJ
    Neuropharmacology; 2018 Sep; 140():174-183. PubMed ID: 30048644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens.
    Ehrich JM; Phillips PE; Chavkin C
    Neuropsychopharmacology; 2014 Dec; 39(13):3036-48. PubMed ID: 24971603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.